Two experts in particle manufacturing for inhaled dry powder formulations, Hovione and Bend research, have entered into a non-exclusive collaboration in which they will have access to each other’s technologies. The partnership also gives Bend access to Hovione’s commercial manufacturing capabilities in Portugal, Ireland, China, and the US.
“Hovione has world-class commercial-scale spray-drying capabilities—both staff and facilities. We’re excited about this collaboration because Hovione will expand the range of manufacturing options available to our clients,” commented Bend CEO Rod Ray.
Dave Hoffman, Hovione VP, Exclusives and Particle Design, added, “Hovione is very pleased to work collaboratively with Bend, a company with such extensive expertise in early and mid-stage development. Leveraging on their capabilities, this collaboration will allow both companies to provide a comprehensive and integrated solution from development to commercial scale.”
The companies emphasize in their press release that both Hovione and Bend have expertise in developing engineered particles for inhalation, and the announcement came on the same day that Hovione launched its new rapid proof of concept service for DPI formulations.
Read the Hovione press release.
